Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAPGEF4 | Q8WZA2 | 4/20 | 0.61 |
| ▸ | CA1 | P00915 | 2/20 | 0.55 |
| ▸ | CA2 | P00918 | 2/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.50 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | UBE2N | P61088 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 3/20 | 0.44 |
| ▸ | MMP2 | P08253 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28139909 | 0.83 | PPME1 (0.51) | RAPGEF4L3MBTL1HTTMMP2ALDH1A1 | |
| SCHEMBL3834757 | 0.81 | RAPGEF4 (0.65) | RAPGEF4CA1CA2L3MBTL1POLB | |
| SCHEMBL3188642 | 0.79 | RAPGEF4 (0.61) | RAPGEF4CA1CA2L3MBTL1POLB | |
| SCHEMBL1365792 | 0.79 | RAPGEF4 (0.61) | RAPGEF4CA1CA2L3MBTL1POLB | |
| SCHEMBL5535689 | 0.79 | RAPGEF4 (0.61) | RAPGEF4CA1CA2L3MBTL1POLB | |
| SCHEMBL23699019 | 0.79 | RAPGEF4 (0.61) | RAPGEF4CA1CA2L3MBTL1POLB | |
| SCHEMBL2457308 | 0.76 | RAPGEF4 (0.58) | RAPGEF4CA1CA2L3MBTL1POLB | |
| SCHEMBL15175998 | 0.76 | RAPGEF4 (1.00) | RAPGEF4CA1CA2L3MBTL1POLB | |
| SCHEMBL19019209 | 0.75 | CA1 (0.50) | RAPGEF4CA1CA2L3MBTL1POLB | |
| SCHEMBL29001261 | 0.75 | CA1 (0.59) | RAPGEF4CA1CA2L3MBTL1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230008117-A1 | LIGHT EMITTING DIODE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-01-12 | — | — | US | disclosed |
| EP-1263759-A2 | AZAINDOLES | Aventis Pharma Limited (GB) | 2002-12-11 | — | — | EP | disclosed |
| WO-2001047922-A2 | AZAINDOLES | AVENTIS PHARMA LIMITED (GB) | 2001-07-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230008117-A1 | LIGHT EMITTING DIODE | CRY1, EFNA1, ALDH1A2 | RAPGEF4 3744/4885CA1 1184/4885CA2 2311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.